Health
New Year, same waiting list woes, for people with arthritis in Wales
VERSUS ARTHRITIS has expressed concern over the latest NHS Wales waiting time figures, highlighting the persistent struggles faced by those awaiting orthopaedic surgery. The charity, which supports people living with arthritis across the UK, called for urgent action from NHS Wales and the Welsh Government to tackle the staggering number of delayed procedures.
Speaking to The Herald, Mary Cowern, Head of Wales at Cymru Versus Arthritis, said: “A new year but the same disappointing news for people with arthritis waiting for orthopaedic surgery in Wales. Though there has been a small decrease in overall Trauma and Orthopaedic (T&O) figures, the number of people waiting over a year has risen.
“NHS Wales remains in uncharted territory, and it’s people with arthritis waiting for surgery who are again paying the price – in pain and losing their mobility and independence.”
Alarming statistics

The latest Trauma and Orthopaedic waiting list figures, covering November 2024, paint a grim picture:
- 102,938 people were waiting for T&O treatment in Wales – a 1% decrease from October 2024.
- 59,828 people (58%) had been waiting longer than 26 weeks, compared to 15,323 people in 2019.
- 47,797 people (46%) had been waiting over 36 weeks, a stark rise from 6,570 people in 2019.
- 32,137 people (31%) had been waiting over a year for treatment, up from just 2,473 in 2019.
- 5,106 people (5%) had been waiting over two years – compared to a mere 76 people in 2019.
These figures reflect a system struggling to recover despite promises of collaboration between NHS Wales and NHS England.
Cross-border collaboration stalled
Ms. Cowern also addressed the ongoing debate around cross-border healthcare. The BMA in Wales recently criticised excessive bureaucracy, which has hindered efforts to streamline patient referrals to NHS England.
“We still await further details on how the cross-border partnership will work,” said Ms. Cowern. “The chaos caused by red tape and bureaucracy needs to be resolved. People with arthritis shouldn’t suffer from systemic failings years on end.”
Powys Teaching Health Board has been a focal point of this issue, with many patients unable to access timely care. Ms. Cowern added:
“The goal of recovery shouldn’t drag us back to pre-pandemic levels. The ambition should be to create something better, with a clear roadmap and realistic targets. All people with arthritis awaiting treatment deserve better.”
A widespread crisis
Arthritis and musculoskeletal conditions affect over 980,000 people in Wales and more than 20 million across the UK. These conditions are a leading cause of persistent pain and disability.
To even join the waiting list for procedures like hip or knee replacements, individuals must already experience significant daily pain, often impacting their ability to work and live independently. Waiting further exacerbates these challenges.
Versus Arthritis is the UK’s largest arthritis charity, dedicated to improving the lives of those living with the condition. Through research, campaigning, and support, the charity says it aims to ensure everyone with arthritis has access to the treatments they need, along with the hope of a cure.
Health
RCN Wales appoints Nicola Williams as Executive Director
NICOLA WILLIAMS will take up the role in April, bringing more than three decades of experience in nursing and senior leadership.
The Royal College of Nursing (RCN) has announced the appointment of Nicola Williams as its new Executive Director for Wales.
She joins the organisation from Velindre University NHS Trust, where she currently serves as Executive Director for Nursing, Allied Health Professionals and Health Care Scientists. With 38 years of experience in nursing and more than six years at executive board level, she is widely recognised across NHS Wales for her work in improving patient outcomes.
A highly experienced strategic leader, Williams has worked across a wide range of clinical and organisational settings. She has led major transformation programmes, strengthened national clinical leadership networks and championed innovation and evidence-based improvements in care. Her work has contributed to changes adopted across Wales and has been recognised with national awards.
Speaking about her appointment, Nicola Williams said: “I feel privileged to be appointed as Executive Director of RCN Wales. I’m a proud nurse, passionate about patient safety and improving care standards.
“Delivering the best care is only possible when nursing staff are supported to work in safe, inclusive environments. I will stand alongside members and their patients.
“Nursing staff are the backbone of health and care. I am determined to support our members across Wales, wherever they work, to meet the challenges ahead and shape the future of our profession.
“I look forward to meeting members across Wales and ensuring our work is informed by their experiences and expertise.”
In her new role, Williams will lead the RCN’s work in Wales and provide strategic leadership across key priority areas spanning the UK.
She succeeds Helen Whyley, who has held the position since February 2019 and will move into a new role as Director of Service Innovation at the RCN.
Health
Decision pending on adult mental health referral pathway
HYWEL DDA University Health Board will decide next week whether to make changes to the GP referral pathway for routine adult mental health services permanent.
The decision will be taken at a public Board meeting on Thursday (Mar 26).
Board members will consider a proposal to formalise changes already introduced in Ceredigion and, if approved, roll out the revised pathway across Pembrokeshire and Carmarthenshire.
Since March 2025, adults in Ceredigion seeking routine mental health support have been advised by their GP to contact the NHS 111 Wales ‘Press 2’ service, rather than being referred directly to the county’s Community Mental Health Team.
The temporary change was introduced in response to ongoing staffing shortages. Health Board officials say the approach has helped maintain timely access to face-to-face assessments for those who need them, while directing initial contact through a single access point.
The 111 ‘Press 2’ service provides telephone assessments by local wellbeing practitioners, supervised by registered mental health nurses, offering advice, support and onward referrals where required.
At its November 2025 meeting, the Board agreed to extend the temporary pathway until the end of March 2026. A nine-week engagement exercise followed, running from December 8 to February 9, to gather feedback from patients, professionals and stakeholders on the potential long-term impact.
Andrew Carruthers, Chief Operating Officer at Hywel Dda University Health Board, said: “I would like to thank everyone who took the time to share their views and experiences.
“I would also like to thank West Wales Action for Mental Health for supporting engagement with patients, including those with lived experience, alongside GPs, primary care teams, mental health staff and third sector partners.
“Our priority is to ensure mental health services remain accessible, fair and sustainable. The temporary changes in Ceredigion have shown some positive benefits, and the feedback we have received from across the three counties will play an important role in shaping the Board’s decision.”
The Board will review all evidence and feedback before making a final decision on the future of the adult mental health referral pathway.
GPs will continue to refer patients with urgent or complex needs directly to community mental health teams where appropriate, and have access to a dedicated NHS 111 professional line for additional clinical advice.
Further details, including the full Board papers, are available here:
https://biphdd.gig.cymru/amdanom-ni/eich-bwrdd-iechyd/cyfarfodydd-y-bwrdd-2026/agenda-a-phapuraur-bwrdd-26-mawrth-2026/
The meeting will be streamed live from 9:30am on Thursday (Mar 26) via:
www.youtube.com/hywelddahealthboard1
Health
Parents urged to check children’s vaccinations after meningitis cases
Local pharmacy reports MenB vaccine shortage amid rising concern
PARENTS and carers across west Wales are being urged to check their children’s vaccination status following recent meningitis cases in the UK.
The warning comes as a local pharmacy has confirmed a shortage of the Meningitis B (MenB) vaccine, highlighting growing pressure on supplies.
Mendus Pharmacy said it currently has no availability of the vaccine due to what it described as a nationwide supply issue.

In a statement, the pharmacy said: “We would like to inform our patients that, due to ongoing supply issues, we currently have no availability of the Meningitis B vaccine.
“Unfortunately, this is a nationwide shortage and all stock is currently unavailable.
“We understand this may be particularly concerning given the recent outbreak reported in Kent, and we completely appreciate the importance of timely vaccination.”
The pharmacy confirmed it is operating a waiting list and will contact patients once supplies return.
Health officials say keeping vaccinations up to date remains one of the most effective ways to prevent serious illness and reduce pressure on NHS services.
Dr Ardiana Gjini, Executive Director of Public Health at Hywel Dda University Health Board, urged parents to act.
She said: “Vaccination is one of the most effective ways we can protect children and young people from serious illness.
“Ensuring your child is fully vaccinated not only safeguards their health but also helps prevent the spread of infections within our communities.
“I strongly encourage all parents and carers to check their child’s vaccination status. If you are concerned that your child may have missed routine vaccinations, please speak to your GP.”
Meningococcal disease is a serious and potentially life-threatening infection that can lead to meningitis or septicaemia. While many people recover, some are left with long-term physical, neurological or psychological complications. Around one in ten cases can be fatal.
Although the disease can affect anyone, babies, young children, teenagers and young adults are at greatest risk.
In Wales, vaccines protecting against meningococcal strains A, B, C, W and Y are offered as part of the NHS immunisation programme. Infants receive the MenB vaccine, while teenagers are offered the MenACWY vaccine.
Latest figures from the Health Board show that uptake among 16-year-olds for the MenACWY vaccine stands at 76.4%, meaning a significant number of young people remain unprotected as they approach adulthood.
For younger children, uptake of the MenB vaccine is higher but still below the recommended 95% target. Around 92.8% of infants are vaccinated by their first birthday, rising slightly to 91.8% by their second.
Health officials say these figures reflect strong engagement from families and primary care teams but stress that continued vigilance is needed.
Families are being advised to check their child’s vaccination record with their GP or by contacting the Health Board directly. Parents should also ensure babies receive their scheduled MenB doses and that teenagers receive their MenACWY and 3-in-1 booster vaccines, which are currently being delivered in schools.
Parents are also urged to remain alert to the symptoms of meningitis and septicaemia and to seek urgent medical advice if they have concerns.
Further information on symptoms is available via NHS 111 Wales.
-
News6 days agoRayner and Lammy visit Wales to discuss justice and community safety
-
News6 days agoFishguard linked to allegations in Many Tears Animal Rescue investigation
-
News3 days agoEmergency services flood Haverfordwest after reports of person in river
-
Local Government6 days agoInvestigation confirmed after inspectors visit Many Tears Animal Rescue
-
Crime2 days agoMother given community order after admitting child cruelty offence
-
Community6 days agoTown hall takeover plan questioned as cost figures conflict
-
Business7 days agoTesco B&Q Haverfordwest click and collect pod approved
-
Business7 days agoLegal action backed in case over development at Dinas Cross










